Epitomics’ chief as a matchmaker for China biotech

Epitomics' chief has line on China partnerships

San Francisco Business Times  Date: Friday, May 6, 2011, Guo-Liang Yu has a plan for China. Now with about 200 employees of his Epitomics Inc. in China — in biotech facilities built courtesy of district-level governments — and two burgeoning Chinese drug partnerships, Yu has become a sort of unofficial tour guide for a half-dozen biotech companies scouting space in the Middle Kingdom. "They are small now," Yu said about the companies he's helped set up operations in the China Medical City complex in Taizhou, "but they'll get bigger." Yu knows from shrewd experience. Epitomics, a Burlingame-based antibody developer whose backers include biotech legend Bill Rutter, has $20 million ..